Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Neurological and cognitive problems news


From To
VACS Index score can help identify HIV-positive people most at risk of neurocognitive decline

A combination of simple, routine blood tests may be able to predict which people living with HIV are especially vulnerable to neurocognitive decline, according to US research published

04 July 2016
Michael Carter
Neurologic symptoms common in early HIV infection

Half of people newly infected with HIV experience neurologic issues, research shows. These neurologic findings are generally not severe and usually resolve after participants started antiretroviral therapy.

14 June 2016
Science Daily
HIV-positive women with childhood trauma have double the brain trouble

HIV-positive women who have endured a trauma such as emotional, physical or sexual abuse, or neglect earlier in their lives are more likely to have trouble remembering, paying attention or multitasking. Parts of their brains are also smaller than women who are only affected by HIV.

26 May 2016
The Conversation
Dementia in HIV -- HAND or Alzheimer's?

Turner and colleagues at Georgetown's Memory Disorders Program argue that the usual diagnosis of dementia in HIV patients -- HIV-associated neurocognitive disorder, or HAND -- might not be the whole picture. And if some patients present with HAND, Alzheimer's or a mixture, Turner told MedPage Today, clinicians will need to broaden their differential diagnosis to get the right therapy.

28 April 2016
MedPage Today HIV/AIDS
First diagnosed case of Alzheimer's disease in HIV-positive individual reported

Georgetown University researchers are reporting the first case of Alzheimer's disease diagnosed in an HIV-positive individual. The finding in a 71-year-old man triggers a realization about HIV survivors now reaching the age when Alzheimer's risk begins to escalate.

15 April 2016
Eurekalert Inf Dis
Antidepressant modestly improves HIV-related cognitive impairment

The SSRI antidepressant paroxetine (Paxil) was associated with modest improvement in cognitive function and reduced central nervous system inflammation in people with HIV-related neurocognitive disorder, but the antifungal drug

31 March 2016
Liz Highleyman
Last Men Standing: The Forgotten Survivors Of AIDS

These men, then in their 20s and 30s, weren’t supposed to make it to 40. Now some are 60 years old, even 70, still alive but wounded physically, psychologically and economically. They also are suffering debilitating health problems, chronic illnesses brought on by a lifetime of living with AIDS and the toxic effects of its treatment. Many live in stark isolation, feeling abandoned and forgotten, even by the gay community they helped build here.

11 March 2016
San Francisco Chronicle
Antidepressant May Improve Cognitive Symptoms in People with HIV

In a small, placebo-controlled clinical trial, Johns Hopkins physicians report that the antidepressant paroxetine modestly improves decision-making and reaction time, and suppresses inflammation in people with HIV-associated cognitive impairment.

26 February 2016
Hopkins Medicine
HIV in the brain: new tools and treatment to keep your mind beautiful

In the future, HIV-associated neurocognitive disorder (HAND) may become less common because of the earlier use of antiretroviral therapy (ART), but neurological disease – caused by a

25 February 2016
Theo Smart
Women and African Americans with HIV have a higher risk of stroke

The risk of stroke among people living with HIV is highest among people with unsuppressed viral load, and among women and African Americans, according to findings presented on

23 February 2016
Keith Alcorn
← First12345...13Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap